$1.61
-0.05-3.01%
Pre-Market: 6:21 PM EDT
Comments
Loading...
ProKidney (PROK) Forecast
NewsEarningsProKidney (PROK) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestProKidney (NASDAQ:PROK) Stock Quotes, Forecast and News Summary
ProKidney Stock (NASDAQ: PROK) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy ProKidney (PROK) stock?
You can purchase shares of ProKidney (NASDAQ:PROK) through any online brokerage.
Who are ProKidney (PROK) competitors?
Other companies in ProKidney’s space includes: Molecular Partners (NASDAQ:MOLN), Macrogenics (NASDAQ:MGNX), Larimar Therapeutics (NASDAQ:LRMR), Tevogen Bio Holdings (NASDAQ:TVGN) and Genfit (NASDAQ:GNFT).
What is the forecast, or price target, for ProKidney (PROK) stock?
ProKidney has a consensus price target of $10.13.
What is the current price for ProKidney (PROK)?
The stock price for ProKidney (NASDAQ: PROK) is $1.61 last updated February 6, 2025 at 6:21 PM EST.
Does ProKidney (PROK) pay a dividend?
There are no upcoming dividends for ProKidney.
When is ProKidney (NASDAQ:PROK) reporting earnings?
ProKidney’s Q4 earnings are confirmed for Friday, March 21, 2025.
Is ProKidney (PROK) going to split?
There is no upcoming split for ProKidney.
What sector and industry does ProKidney (PROK) operate in?
ProKidney is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.